Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Jia Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: COVID-19, Stomach Neoplasms, Esophageal Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In contemporary literature, little attention has been paid to the association between coronavirus disease‐2019 (COVID‐19) and cancer risk. We performed the Mendelian randomization (MR) to investigate the causal associations between the three types of COVID‐19 exposures (critically ill COVID‐19, hospitalized COVID‐19, and respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection) and 33 different types of cancers of the European population. The results of the inverse‐variance‐weighted model indicated that genetic liabilities to critically ill COVID‐19 had suggestive causal associations with the increased risk for HER2‐positive breast cancer (odds ratio [OR] = 1.0924; p ‐value = 0.0116), esophageal cancer (OR = 1.0004; p ‐value = 0.0226), colorectal cancer (OR = 1.0010; p ‐value = 0.0242), stomach cancer (OR = 1.2394; p ‐value = 0.0331), and colon cancer (OR = 1.0006; p ‐value = 0.0453). The genetic liabilities to hospitalized COVID‐19 had suggestive causal associations with the increased risk for HER2‐positive breast cancer (OR = 1.1096; p ‐value = 0.0458), esophageal cancer (OR = 1.0005; p ‐value = 0.0440) as well as stomach cancer (OR = 1.3043; p ‐value = 0.0476). The genetic liabilities to SARS‐CoV‐2 infection had suggestive causal associations with the increased risk for stomach cancer (OR = 2.8563; p ‐value = 0.0019) but with the decreasing risk for head and neck cancer (OR = 0.9986, p ‐value = 0.0426). The causal associations of the above combinations were robust through the test of heterogeneity and pleiotropy. Together, our study indicated that COVID‐19 had causal effects on cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zitieren
APA
Li, J., Bai, H., Qiao, H., Du, C., Yao, P., Zhang, Y., Cai, Y., Jia, Y., Wei, X., Li, C., Liu, X., Wang, W., Sun, S., Feng, C., Hu, Y., Zhou, Z., Zhang, S., & Zhang, Y. (2023). Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study. Journal of Medical Virology. https://doi.org/10.1002/jmv.28722
Vancouver
Li J, Bai H, Qiao H, Du C, Yao P, Zhang Y, et al. Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study. Journal of Medical Virology. 2023. doi:10.1002/jmv.28722
BibTeX
@article{Li2023,
author = {Li, Jia and Bai, Haocheng and Qiao, Hao and Du, Chong and Yao, Peizhuo and Zhang, Yu and Cai, Yifan and Jia, Yiwei and Wei, Xinyu and Li, Chaofan and Liu, Xuanyu and Wang, Weiwei and Sun, Shiyu and Feng, Cong and Hu, Yijian and Zhou, Zhangjian and Zhang, Shuqun and Zhang, Yinbin},
title = {Causal effects of COVID‐19 on cancer risk: A Mendelian randomization study},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28722}
}
EUVIMED